Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
종목 코드 FTRE
회사 이름Fortrea Holdings Inc
상장일Jun 16, 2023
CEOMr. Anshul Thakrala
직원 수15500
유형Ordinary Share
회계 연도 종료Jun 16
주소8 Moore Drive
도시DURHAM
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호27709
전화18774950816
웹사이트https://www.fortrea.com/
종목 코드 FTRE
상장일Jun 16, 2023
CEOMr. Anshul Thakrala
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음